Poland - Chemical reagents
For more information and to make a bid you will need to go to the third party website.
Details
Provided by- Opportunity closing date
- 19 June 2019
- Opportunity publication date
- 15 May 2019
- Category
- 33696300: Chemical reagents
- Value of contract
- £100k-1m
- Your guide to exporting
Description
Reagents and consumables to confirm the presence of anti-HIV1 and anti-HIV2 antibodies according to the catalog numbers of the designated manufacturer or equivalent with lease of automatic track analysis. Reagents and consumables to confirm the presence of anti-HCV, treponema pallidum and HTLV antibodies according to the catalog numbers of the designated manufacturer or equivalent, together with the lease of an automated analyser. Reagents and consumables of immuno-hematological apparatus according to the catalogue numbers of the designated manufacturer or equivalent with lease of an automated analyser Laboratory reagents/kits/tests and consumables for haemostasis testing according to the catalogue numbers of the designated manufacturer or equivalent with lease of three analysers. Reagents/laboratory kits/tests and consumables for the performance of primary haemostasis tests carried out under the catalogues of a designated manufacturer or equivalent with the hire of an analyser Reagents and consumables for the immunofixation of Sebia Hydrasys 2 apparatus carried out under the catalogues of a designated manufacturer or equivalent. LSI MYC BA Rearrangement Molecular Probe Testing including all reagents and consumables for HLA-A, B, C, DRB1, DQB1, DQB1 genotyping at a high resolution level by sequencing. Reagents according to the part number of the designated manufacturer or equivalent
- Opportunity closing date
- 19 June 2019
- Value of contract
- £100k-1m
About the buyer
- Address
- Instytut Hematologii i Transfuzjologii ul. Indiry Gandhi 14 Warszawa 02-776 Poland
- Contact
- zaopat@ihit.waw.pl
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.